| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 7014- | Fuc, | 5-FU, | Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Colon, | Caco-2 |
| 7016- | Fuc, | Therapies from Fucoidan: New Developments |
| - | Review, | Var, | NA |
| 7018- | Fuc, | Absorption Study of Mozuku Fucoidan in Japanese Volunteers |
| - | Trial, | Nor, | NA |
| 7025- | Fuc, | Pilot clinical study to evaluate the anticoagulant activity of fucoidan |
| - | Human, | Nor, | NA |
| 7021- | Fuc, | Fucoidan Prevents the Progression of Osteoarthritis in Rats |
| - | in-vivo, | Arthritis, | NA |
| 7007- | Fuc, | The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles |
| - | Review, | Var, | NA |
| 4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
| - | Review, | AD, | NA |
| - | in-vitro, | Oral, | NA |
| 4028- | FulvicA, | Mineral pitch induces apoptosis and inhibits proliferation via modulating reactive oxygen species in hepatic cancer cells |
| - | in-vitro, | Liver, | HUH7 |
| 4026- | FulvicA, | Shilajitin Cancer Treatment: Probable Mode of Action |
| - | Review, | Var, | NA |
| 7044- | GA, | QC, | Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity |
| - | in-vitro, | BC, | MCF7 |
| 7032- | GA, | Cisplatin, | Gallic acid: a polyphenolic compound potentiates the therapeutic efficacy of cisplatin in human breast cancer cells |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 |
| 1624- | GA, | Anticancer Effect of Pomegranate Peel Polyphenols against Cervical Cancer |
| - | in-vitro, | Cerv, | NA |
| 7833- | GA, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| - | Trial, | Nor, | NA |
| 7071- | GABA, | Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks |
| - | Trial, | Nor, | NA |
| 7075- | GABA, | Effects of γ-aminobutyric acid supplementation on glucose control in adults with prediabetes: A double-blind, randomized, placebo-controlled trial |
| - | Trial, | Diabetic, | NA |
| 7076- | GABA, | Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study |
| - | Trial, | Nor, | NA |
| - | Trial, | Nor, | NA |
| 7080- | GABA, | The Effect of Oral GABA on the Nervous System: Potential for Therapeutic Intervention |
| - | Review, | AD, | NA |
| 7081- | GABA, | Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut–Brain Axis |
| - | Review, | AD, | NA |
| 1955- | GamB, | Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancer |
| - | in-vitro, | Pca, | PC3 | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 |
| 1954- | GamB, | Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase |
| - | in-vitro, | HCC, | SMMC-7721 cell |
| 7054- | GamB, | An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors |
| - | Trial, | Var, | NA |
| 7085- | GAR, | Safety profile of 40% Garcinol from Garcinia indica in experimental rodents |
| - | in-vivo, | Nor, | NA |
| - | in-vivo, | Nor, | NA |
| 1636- | GAR, | Dangerous dietary supplements: Garcinia cambogia-associated hepatic failure requiring transplantation |
| - | Case Report, | Obesity, | NA |
| 7226- | GBE, | Ginkgo biloba exocarp extracts induces apoptosis in Lewis lung cancer cells involving MAPK signaling pathways |
| - | vitro+vivo, | Lung, | NA |
| 7223- | GBE, | Ginkgo biloba Exocarp Extract Inhibits the Metastasis of B16-F10 Melanoma Involving PI3K/Akt/NF- κ B/MMP-9 Signaling Pathway |
| - | vitro+vivo, | Melanoma, | B16-F10 |
| 8582- | GBE, | Cro, | Sage, | MO, | A comprehensive systematic review of human trials investigating herbal treatments for Alzheimer’s disease and dementia |
| - | Review, | AD, | NA |
| - | vitro+vivo, | HCC, | NA |
| 7206- | GBE, | EGb 761, | Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review |
| - | Review, | AD, | NA |
| 7189- | GBE, | Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx] |
| - | Trial, | Nor, | NA |
| 7188- | GBE, | Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial |
| - | Trial, | AD, | NA |
| 7212- | GBE, | The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease |
| - | Review, | AD, | NA |
| 7187- | GBE, | Ginkgo biloba for prevention of dementia: a randomized controlled trial |
| - | Trial, | AD, | NA |
| 7670- | GCL2505, | Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial |
| - | Trial, | AD, | NA |
| 7130- | Ge-132, | Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer |
| - | Trial, | BC, | NA |
| 7124- | Ge-132, | Physiological Activity of Trace Element Germanium including Anticancer Properties |
| - | Review, | Var, | NA |
| 7107- | GEN, | Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients |
| - | Trial, | Pca, | NA | - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | PC3 |
| 7109- | GEN, | Single- and multiple-dose pharmacokinetics of genistein capsules in healthy chinese subjects: A phase I, randomized, open-label study |
| - | Trial, | Nor, | NA |
| - | Trial, | Pca, | NA |
| 7110- | GEN, | Genistein |
| - | Review, | AD, | NA |
| 7105- | GEN, | Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer |
| - | Trial, | Pca, | NA |
| - | Trial, | Pca, | NA |
| 7102- | GEN, | Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits |
| - | Review, | Var, | NA |
| 7112- | GEO2, | Hazard assessment of germanium supplements |
| - | Review, | Var, | NA |
| 7113- | GEO2, | Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide |
| - | Review, | Nor, | NA |
| 6564- | Ger, | Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2 |
| - | in-vitro, | HCC, | HepG2 |
| 6567- | Ger, | Geraniin inhibits proliferation and induces apoptosis through inhibition of phosphatidylinositol 3-kinase/Akt pathway in human colorectal cancer in vitro and in vivo |
| - | vitro+vivo, | CRC, | SW480 | - | in-vitro, | CRC, | HT29 |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid